TEMPEST THERAPEUTICS INC (TPST:NASDAQ)
$0.7601 -0.0099 (-1.2857%)
Analysed TEMPEST THERAPEUTICS INC (TPST:NASDAQ) News Sources
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
14-05-2026
yahoo.com
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
29-05-2026
yahoo.com
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
04-06-2026
yahoo.com
Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
15-07-2026
yahoo.com
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
21-07-2026
yahoo.com
Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
13-08-2026
yahoo.com
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08-09-2026
yahoo.com
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
11-09-2026
yahoo.com
Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
15-09-2026
yahoo.com
Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors
23-09-2026
yahoo.com
What is the current price of TEMPEST THERAPEUTICS INC (TPST:NASDAQ)?
The current price of TEMPEST THERAPEUTICS INC (TPST:NASDAQ) is $0.7601.
TEMPEST THERAPEUTICS INC (TPST:NASDAQ) absolute price change since previous trading day?
The absolute price change of TEMPEST THERAPEUTICS INC (TPST:NASDAQ) since the previous trading day is $-0.0099.
TEMPEST THERAPEUTICS INC (TPST:NASDAQ) percentage price change since previous trading day?
The percentage price change of TEMPEST THERAPEUTICS INC (TPST:NASDAQ) since the previous trading day is -1.2857%.
What is the most recent average sentiment score for TEMPEST THERAPEUTICS INC (TPST:NASDAQ)?
The most recent average sentiment score for TEMPEST THERAPEUTICS INC (TPST:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for TEMPEST THERAPEUTICS INC (TPST:NASDAQ)?
The most recent sentiment for TEMPEST THERAPEUTICS INC (TPST:NASDAQ) is .
SEC-8K** Filing Available For TEMPEST THERAPEUTICS INC (TPST:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.